Form 4: Agenus Director Susan B. Hirsch Granted 15,000 Stock Options Under Equity Incentive Plan

Agenus Inc. Director Susan B. Hirsch was granted 15,000 stock options with an exercise price of $3.02, vesting one year from the grant date, following shareholder approval.

Summary

• Susan B. Hirsch, a Director of Agenus Inc. (AGEN), reported the acquisition of 15,000 derivative securities in the form of stock options.
• The options were granted on May 28, 2025, and became effective following shareholder approval obtained at the Company's annual shareholder meeting on June 17, 2025.
• Each option has an exercise price of $3.02 per share.
• The options vest on the one-year anniversary of the grant date, which is May 28, 2026.
• The expiration date for these stock options is May 28, 2035.
• The grant was made in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan.
• Following this transaction, Susan B. Hirsch beneficially owns 15,000 derivative securities directly.

Sentiment

Score: 6

Explanation: The document reports a routine stock option grant to a director, which is generally a neutral to slightly positive event as it aligns insider interests with shareholders, without indicating any significant operational or financial changes.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders, incentivizing long-term company performance.
• The transaction was conducted under an existing, shareholder-approved equity incentive plan, indicating adherence to established corporate governance practices.

Future Outlook

The stock options granted to Director Susan B. Hirsch are scheduled to vest on May 28, 2026, one year from their grant date, and will expire on May 28, 2035.

Industry Context

This filing is a routine disclosure of insider compensation, common across all industries, particularly in biotechnology where equity incentives are a standard component of executive and director remuneration to align long-term interests.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of options aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: While not directly impacting employees, the use of equity incentive plans can set a precedent for compensation structures across the organization.

Next Steps

• The stock options will vest on May 28, 2026, allowing the director to exercise them thereafter.

Key Dates

Keywords

Agenus Inc., AGEN, Stock Option, Director Compensation, SEC Form 4, Insider Transaction, Equity Incentive Plan, Beneficial Ownership